首页> 外文OA文献 >OMERACT-OARSI ‘strict responders’ analysis from results of a randomized, double-blind, placebo-controlled phase 1 study of a novel, intra-articular, injectable, Wnt inhibitor (SM04690) in the treatment of osteoarthritis of the knee

【2h】

OMERACT-OARSI ‘strict responders’ analysis from results of a randomized, double-blind, placebo-controlled phase 1 study of a novel, intra-articular, injectable, Wnt inhibitor (SM04690) in the treatment of osteoarthritis of the knee

机译：Omeract-Oarsi'严格的响应者的分析来自随机，双盲，安慰剂对照阶段1研究的研究结果，在膝盖的骨关节炎的治疗中进行了一种新型，术中，注射的WNT抑制剂（SM04690）的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Y. Yazici; J. Tambiah; C.J. Swearingen; A. DiFrancesco; V. Strand;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS [J] . Yazici Y., McAlindon T. E., Gibofsky A., Osteoarthritis and cartilage . 2018 ,第Suppla1期

机译：52周随机化，双盲，安慰剂控制，2阶段研究新颖的，关节内的WNT途径抑制剂（SM04690）的治疗，用于治疗膝关节骨关节炎
2. RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS [J] . Yazici Y., McAlindon T. E., Gibofsky A., Osteoarthritis and cartilage . 2018 ,第Suppla1期

机译：52周随机化，双盲，安慰剂控制，2阶段研究新颖的，关节内的WNT途径抑制剂（SM04690）的治疗，用于治疗膝关节骨关节炎
3. RADIOGRAPHIC OUTCOMES WERE CONCORDANT WITH OUTCOME MEASURES IN RHEUMATOLOGY-OSTEOARTHRITIS RESEARCH SOCIETY INTERNATIONAL (OMERACT-OARSI) STRICT RESPONSE: POST-HOC ANALYSIS FROM A PHASE 2 STUDY OF A WNT PATHWAY INHIBITOR, SM04690, FOR KNEE OSTEOARTHRITIS TREATMENT [J] . Yazici Y., McAlindon T. E., Gibofsky A., Osteoarthritis and cartilage . 2018 ,第Suppla1期

机译：射线照相结果与风湿病学 - 骨关节炎研究会的结果措施协调一致（OMERACT-OARSI）严格反应：HOC后2阶段分析来自WNT途径抑制剂，SM04690，用于膝关节骨关节炎治疗
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. The efficacy and safety of S-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase II randomized double-blind placebo-controlled dose-finding study [O] . Ikuko Yataba, Noboru Otsuka, Isao Matsushita, 2017

机译：S-氟比洛芬膏药治疗膝部骨关节炎的有效性和安全性：II期随机双盲安慰剂对照剂量寻找研究
6. SAT0552 Clinical outcomes from a randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, injectable, WNT pathway inhibitor (SM04690) for the treatment of knee osteoarthritis: week 26 interim analysis [O] . Y Yazici, A Gibofsky, NE Lane, 2017

机译：SAT0552 SAT0552从随机，双盲，安慰剂控制，相2研究的临床结果，用于治疗膝关节骨关节炎的新型，关节式，注射，WNT途径抑制剂（SM04690）的研究：周26临时分析

OMERACT-OARSI ‘strict responders’ analysis from results of a randomized, double-blind, placebo-controlled phase 1 study of a novel, intra-articular, injectable, Wnt inhibitor (SM04690) in the treatment of osteoarthritis of the knee

著录项

相似文献

相关主题

期刊订阅